7/24/2014

The Defense Advanced Research Projects Agency has tapped NeuroPace to investigate the use of implantable neurostimulators to treat memory loss in patients with epilepsy. The research will involve patients implanted with NeuroPace's RNS System, an FDA-approved device that uses neurostimulation to help epilepsy patients avoid seizures.

Related Summaries